Medical Weight Loss for Pittsburgh, Pennsylvania Residents

Pittsburgh, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Pittsburgh through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Wondering if you qualify in Pittsburgh? Eligibility for compounded GLP-1 care is confirmed by Dr. Sharma during your video visit, based on your health history, not your zip code in Pennsylvania. Doctor review just $119 (medication separate).

Why Pittsburgh Residents Choose New Hope Weight Loss

New Hope keeps the money part simple so you can focus on the health part. For Pittsburgh patients that means semaglutide from $166 monthly, tirzepatide from $233 monthly, a $119 physician visit, no insurance required, and no penalty for living outside Costa Mesa. We take HSA, FSA, Klarna, and Affirm, so paying out of pocket does not have to mean paying all at once. Clear terms, no games.

Pittsburgh is served through telehealth from our Costa Mesa, California clinic. The consultation, prescription, and follow-ups all happen by secure video, no travel to California required.

You do not need a clinic on your street in Pittsburgh to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Pennsylvania by secure telehealth. We care for patients throughout Downtown, the Strip District, Shadyside, Squirrel Hill, the South Side, and the greater Pittsburgh area. Because everything happens by telehealth, patients across Downtown, the Strip District, Shadyside, Squirrel Hill, the South Side, and the greater Pittsburgh area get the same physician-led program without driving anywhere or sitting in a waiting room.

Telehealth lets you skip the commute entirely, so the time you would have spent driving across Pittsburgh goes straight into starting your program. Compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and for Pittsburgh patients it starts at $166 per month, billed separately. Pennsylvania is one of the most populous states in the country, and New Hope Weight Loss serves patients across it by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for Pittsburgh patients.

How Telehealth Works for Pittsburgh

No waiting rooms, no commute across Pittsburgh traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your Pittsburgh home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, Pittsburgh

How does someone in Pittsburgh access New Hope Weight Loss?

Access from Pittsburgh is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Pittsburgh, Pennsylvania through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Pittsburgh residents?

A clinic visit is never part of it for Pittsburgh. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Pittsburgh inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Pittsburgh patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Pittsburgh residents are charged no distance surcharge.

What areas of Pittsburgh do you serve?

We serve patients from across Pittsburgh by telehealth, including Downtown, the Strip District, Shadyside, Squirrel Hill, the South Side, and the greater Pittsburgh area.

How does the first telehealth appointment work for Pittsburgh patients?

Start with the 2-minute quiz or the medical intake form. Dr. Sharma reviews your history by secure video, and if you are a candidate and telehealth-eligible, your prescription goes to the 503(a) pharmacy for shipping to Pittsburgh.

Pittsburgh Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Pittsburgh, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.